Skip to main content

Table 2 Univariate analysis for level VII lymph node metastasis in 275 PTC patients

From: Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients

Variablesa

Level VII lymph node metastasis

P-value

Present

Absent

Gender, n (%)

79

196

 

Male

22 (34.92)

41 (65.08)

0.267

Female

57 (26.89)

155 (73.11)

Age in years, mean (SD)

43.47 (13.32)

47.12 (11.33)

0.034

Poor differentiation, n (%)

0.001

 Yes

7 (87.5)

1 (12.5)

 No

72 (26.97)

195 (73.03)

Multifocality, n (%)

0.007

 Yes

43 (37.72)

71 (62.28)

 No

36 (22.36)

125 (77.64)

PTMC, n (%)

< 0.001

 Yes

36 (20.57)

139 (79.43)

 No

43 (43.0)

57 (57.0)

US (+) LNM, n (%)

< 0.001

 Yes

43 (58.11)

31 (41.89)

 No

36 (17.91)

165 (82.09)

Location of US (+) LNM, n (%)

0.155

 Lateral Compartment

24 (50.0)

24 (50.0)

 Central Compartment

3 (75.0)

1 (25.0)

 Both

16 (72.73)

6 (27.27)

Gross lymph node metastasis, n (%)

< 0.001

 Yes

53 (41.09)

76 (58.91)

 No

26 (17.81)

120 (82.19)

Extrathyroidal extension, n (%)

  

0.003

Yes

26 (45.61)

31 (54.39)

No

53 (24.31)

165 (75.69)

Hashimoto thyroiditis, n (%)

0.128

 Yes

15 (21.13)

56 (78.87)

 No

64 (31.37)

140 (68.63)

Location of primary carcinoma, n (%)

0.005

 Upper third

14 (16.09)

73 (83.91)

 Middle third

29 (35.37)

53 (64.63)

 Lower third

36 (33.96)

70 (66.04)

  1. aContinuous variables are presented as means and standard deviations (SD); categorical variables are presented as n (%). PTC papillary thyroid carcinoma, PTMC papillary thyroid microcarcinoma, US (+) LNM ultrasonography-positive lymph node metastasis